Siderocillin

Drug Profile

Siderocillin

Alternative Names: SDGC-01; SDGC-01 Gallium Citrate IV

Latest Information Update: 11 Apr 2014

Price : $50

At a glance

  • Originator Sideromics
  • Class Antibacterials; Drug conjugates; Penicillins
  • Mechanism of Action Bacterial growth inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Bacteraemia; Skin and soft tissue infections
  • Research Plague

Most Recent Events

  • 11 Apr 2014 Early research in Plague in USA (IV)
  • 08 Apr 2014 Preclinical trials in Skin and soft tissue infections in USA (IV)
  • 08 Apr 2014 Preclinical trials in Bacteraemia in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top